Dihydromyricetin promotes hepatocellular carcinoma regression via a p53 activation-dependent mechanism.
about
Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/Bcl-2 Pathway in Hepatocellular Carcinoma CellsDihydromyricetin Induces Apoptosis and Reverses Drug Resistance in Ovarian Cancer Cells by p53-mediated Downregulation of SurvivinDihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin.BSN723T Prevents Atherosclerosis and Weight Gain in ApoE Knockout Mice Fed a Western Diet.Dihydromyricetin protects neurons in an MPTP-induced model of Parkinson's disease by suppressing glycogen synthase kinase-3 beta activity.Diosmetin inhibits cell proliferation and induces apoptosis by regulating autophagy via the mammalian target of rapamycin pathway in hepatocellular carcinoma HepG2 cells.Diosmetin inhibits the metastasis of hepatocellular carcinoma cells by downregulating the expression levels of MMP-2 and MMP-9.Krüppel-like factor 8 promotes cancer stem cell-like traits in hepatocellular carcinoma through Wnt/β-catenin signaling.Targeting of growth factors in the treatment of hepatocellular carcinoma: The potentials of polysaccharides.Systematic Analysis of Quantitative Logic Model Ensembles Predicts Drug Combination Effects on Cell Signaling NetworksMolecular mechanisms of ampelopsin from Ampelopsis megalophylla induces apoptosis in HeLa cells.The Versatile Effects of Dihydromyricetin in Health.Dihydromyricetin-mediated inhibition of the Notch1 pathway induces apoptosis in QGY7701 and HepG2 hepatoma cells.Diosmetin induces apoptosis by upregulating p53 via the TGF-β signal pathway in HepG2 hepatoma cellsTargeting P-glycoprotein and SORCIN: Dihydromyricetin strengthens anti-proliferative efficiency of adriamycin via MAPK/ERK and Ca2+ -mediated apoptosis pathways in MCF-7/ADR and K562/ADR.Gastrointestinal stability of dihydromyricetin, myricetin, and myricitrin: an in vitro investigation.Flavonoids Effects on Hepatocellular Carcinoma in Murine Models: A Systematic Review.
P2860
Q28546762-78984C87-6C52-4694-BDB3-7EF262EF5419Q33594379-C349859A-BB5F-4CE0-8E3E-4E8981B9B1B6Q35550223-7F97B6EA-CAF1-4C72-9E48-59DF4B5EB8B2Q37284232-98EDD3AA-5EA5-47B3-8FD8-D11F5EE4686AQ37325666-B10D10AC-2457-40B8-AD1B-4FA1DCA5DAF6Q37581764-F6DED251-F6F6-43CE-81FB-B0A2492F6C0AQ38650926-BF498636-31B4-4B74-8B08-2D1CFA6637C8Q38754448-9606E3AB-B871-46FA-88C1-7E3624092E4CQ39270408-6DC47138-A35E-49A4-8991-8C3EE42471BAQ41582124-B3026EDB-15CA-4646-B4F2-38AD997DEA21Q41612931-B205FE73-B827-49B1-A363-B2E1ADFDE5ADQ41692078-273B8947-9585-41A2-AA8F-91DF708B60D6Q42360452-771D1304-07F2-4E7D-91DB-94C9AF843A0AQ42555334-D20A609A-8CB2-4B4C-9A38-51F6DAFC088DQ48168156-26E67813-2A09-425C-9933-70C9C5B51351Q53554185-E116C38B-0510-4559-B0E6-EA7ED7E9D96FQ54230737-AA99CC9F-B73F-4056-9927-00D9381445C8
P2860
Dihydromyricetin promotes hepatocellular carcinoma regression via a p53 activation-dependent mechanism.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 April 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dihydromyricetin promotes hepa ...... ctivation-dependent mechanism.
@en
Dihydromyricetin promotes hepa ...... ctivation-dependent mechanism.
@nl
type
label
Dihydromyricetin promotes hepa ...... ctivation-dependent mechanism.
@en
Dihydromyricetin promotes hepa ...... ctivation-dependent mechanism.
@nl
prefLabel
Dihydromyricetin promotes hepa ...... ctivation-dependent mechanism.
@en
Dihydromyricetin promotes hepa ...... ctivation-dependent mechanism.
@nl
P2093
P2860
P356
P1433
P1476
Dihydromyricetin promotes hepa ...... ctivation-dependent mechanism.
@en
P2093
Chen Zhang
Nianping Chen
Qingyu Zhang
Runzhi Zhu
Xiaofeng Chen
P2860
P2888
P356
10.1038/SREP04628
P407
P577
2014-04-10T00:00:00Z
P5875
P6179
1047587894